Related references
Note: Only part of the references are listed.Two models for weight gain and hyperphagia as side effects of atypical antipsychotics in male rats: Validation with olanzapine and ziprasidone
Miwako Shobo et al.
BEHAVIOURAL BRAIN RESEARCH (2011)
Exposure to a social stressor alters the structure of the intestinal microbiota: Implications for stressor-induced immunomodulation
Michael T. Bailey et al.
BRAIN BEHAVIOR AND IMMUNITY (2011)
Weight Gain and Changes in Metabolic Variables following Olanzapine Treatment in Schizophrenia and Bipolar Disorder
Leslie Citrome et al.
CLINICAL DRUG INVESTIGATION (2011)
Lipogenic effects of psychotropic drugs: focus on the SREBP system
Johan Ferno et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2011)
Olanzapine promotes fat accumulation in male rats by decreasing physical activity, repartitioning energy and increasing adipose tissue lipogenesis while impairing lipolysis
V. L. Albaugh et al.
MOLECULAR PSYCHIATRY (2011)
Overweight induced by chronic risperidone exposure is correlated with overexpression of the SREBP-1c and FAS genes in mouse liver
Emilie Lauressergues et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2011)
Composition and energy harvesting capacity of the gut microbiota: relationship to diet, obesity and time in mouse models
E. F. Murphy et al.
GUT (2010)
Relationship between body mass index and insulin resistance in patients treated with second generation antipsychotic agents
Sun H. Kim et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2010)
Recognition of peptidoglycan from the microbiota by Nod1 enhances systemic innate immunity
Thomas B. Clarke et al.
NATURE MEDICINE (2010)
Lean mean fat reducing ghrelin machine: Hypothalamic ghrelin and ghrelin receptors as therapeutic targets in obesity
Harriet Schellekens et al.
NEUROPHARMACOLOGY (2010)
Increased Food Intake and Energy Expenditure Following Administration of Olanzapine to Healthy Men
Robert J. Fountaine et al.
OBESITY (2010)
The role of histaminergic H1 and H3 receptors in food intake: A mechanism for atypical antipsychotic-induced weight gain?
Chao Deng et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2010)
Sensitivity of the female rat to olanzapine-induced weight gain-Far from the clinic?
Katrina Weston-Green et al.
SCHIZOPHRENIA RESEARCH (2010)
Preclinical models of antipsychotic drug-induced metabolic side effects
Heidi N. Boyda et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2010)
Effect of treatment on weight gain and metabolic abnormalities in patients with first-episode psychosis
Swapna Verma et al.
AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY (2009)
How can antipsychotics cause diabetes mellitus? Insights based on receptor-binding profiles, humoral factors and transporter proteins
F. C. J. Starrenburg et al.
EUROPEAN PSYCHIATRY (2009)
Cardiometabolic Risk of Second-Generation Antipsychotic Medications During First-Time Use in Children and Adolescents
Christoph U. Correll et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
Second-Generation Antipsychotic-Associated Diabetes Mellitus and Diabetic Ketoacidosis: Mechanisms, Predictors, and Screening Need
Dan Cohen et al.
JOURNAL OF CLINICAL PSYCHIATRY (2009)
Olanzapine Plasma Concentrations After Treatment With 10, 20, and 40 mg/d in Patients With Schizophrenia An Analysis of Correlations With Efficacy, Weight Gain, and Prolactin Concentration
Leslie Citrome et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2009)
Antipsychotic-induced body weight gain: Predictors and a systematic categorization of the long-term weight course
Stefan Gebhardt et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2009)
A core gut microbiome in obese and lean twins
Peter J. Turnbaugh et al.
NATURE (2009)
Atypical antipsychotics suppress production of proinflammatory cytokines and up-regulate interleukin-10 in lipopolysaccharide-treated mice
Haruhiko Sugino et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2009)
Effects of clozapine and olanzapine on cytokine systems are closely linked to weight gain and drug-induced fever
Michael Kluge et al.
PSYCHONEUROENDOCRINOLOGY (2009)
Acute clozapine exposure in vivo induces lipid accumulation and marked sequential changes in the expression of SREBP, PPAR, and LXR target genes in rat liver
Johan Ferno et al.
PSYCHOPHARMACOLOGY (2009)
Early perturbation in feeding behaviour and energy homeostasy in olanzapine-treated rats
Montserrat Victoriano et al.
PSYCHOPHARMACOLOGY (2009)
Metabolic profiles of second-generation antipsychotics in early psychosis: Findings from the CAFE study
Jayendra K. Patel et al.
SCHIZOPHRENIA RESEARCH (2009)
Glucose and lipid disturbances after 1 year of antipsychotic treatment in a drug-naive population
Rocio Perez-Iglesias et al.
SCHIZOPHRENIA RESEARCH (2009)
Factors associated with weight gain during olanzapine treatment in patients with schizophrenia or bipolar disorder: Results from a six-month prospective, multinational, observational study
Tamas Treuer et al.
WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY (2009)
Diet-induced obesity is linked to marked but reversible alterations in the mouse distal gut microbiome
Peter J. Turnbaugh et al.
CELL HOST & MICROBE (2008)
Insulin sensitivity, adjusted β-cell function and adiponectinaemia among lean drug-naive schizophrenic patients treated with atypical antipsychotic drugs: A nine-month prospective study
P. Oriot et al.
DIABETES & METABOLISM (2008)
Serotonin 5-HT2C receptor agonist promotes hypophagia via downstream activation of melanocortin 4 receptors
Daniel D. Lam et al.
ENDOCRINOLOGY (2008)
Gender Difference in the Composition of Fecal Flora in Laboratory Mice, as Detected by Denaturing Gradient Gel Electrophoresis (DGGE)
Seigo Fushuku et al.
EXPERIMENTAL ANIMALS (2008)
Dyslipidemia independent of body mass in anti psychotic-treated patients under real-life conditions
Astrid B. Birkenaes et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2008)
Ethnic heterogeneity in glucoregulatory function during treatment with atypical antipsychotics in patients with schizophrenia
Marilyn Ader et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2008)
Polysaccharide utilization by gut bacteria: potential for new insights from genomic analysis
Harry J. Flint et al.
NATURE REVIEWS MICROBIOLOGY (2008)
Simultaneous Assessment of Soil Microbial Community Structure and Function through Analysis of the Meta-Transcriptome
Tim Urich et al.
PLOS ONE (2008)
Chronic clozapine treatment in female rats does not induce weight gain or metabolic abnormalities but enhances adiposity: Implications for animal models of antipsychotic-induced weight gain
G. D. Cooper et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2008)
Leptin and Ghrelin Levels in Patients With Schizophrenia During Different Antipsychotics Treatment: A Review
Othman Sentissi et al.
SCHIZOPHRENIA BULLETIN (2008)
Insulin resistance following continuous, chronic olanzapine treatment: An animal model
Araba F. Chintoh et al.
SCHIZOPHRENIA RESEARCH (2008)
Association between antipsychotics and weight gain among psychiatric outpatients in Pakistan: a retrospective cohort study
Syed Ahmer et al.
Annals of General Psychiatry (2008)
Clozapine and olanzapine are associated with food craving and binge eating -: Results from a randomized double-blind study
Michael Kluge et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2007)
Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia
P. D. Cani et al.
DIABETOLOGIA (2007)
Effect of chronic infusion of olanzapine and clozapine on food intake and body weight gain in male and female rats
SuJean Choi et al.
LIFE SCIENCES (2007)
Olanzapine induces SREBP-1-related adipogenesis in 3T3-L1 cells
Li-Hung Yang et al.
PHARMACOLOGICAL RESEARCH (2007)
MEGAN analysis of metagenomic data
Daniel H. Huson et al.
GENOME RESEARCH (2007)
Olanzapine-induced weight gain and increased visceral adiposity is blocked by melatonin replacement therapy in rats
Murray A. Raskind et al.
NEUROPSYCHOPHARMACOLOGY (2007)
Mechanisms underlying the resistance to diet-induced obesity in germ-free mice
Fredrik Backhed et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Differences between men and women in side effects of second-generation antipsychotics
W. Aichhorn et al.
NERVENARZT (2007)
SREBP-1c transcription factor and lipid homeostasis: Clinical perspective
P. Ferre et al.
HORMONE RESEARCH (2007)
An obesity-associated gut microbiome with increased capacity for energy harvest
Peter J. Turnbaugh et al.
NATURE (2006)
Treatment of psychosis: 30 years of progress
I. R. De Oliveira et al.
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS (2006)
Drug-induced activation of SREBP-controlled lipogenic gene expression in CNS-related cell lines:: Marked differences between various antipsychotic drugs
Johan Ferno et al.
BMC NEUROSCIENCE (2006)
Circulating levels of MCP-1 and IL-8 are elevated in human obese subjects and associated with obesity-related parameters
C-S Kim et al.
INTERNATIONAL JOURNAL OF OBESITY (2006)
SREBP activation by antipsychotic- and antidepressant-drugs in cultured human liver cells: Relevance for metabolic side-effects?
Maria B. Raeder et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2006)
Long term treatment with olanzapine mixed with the food in male rats induces body fat deposition with no increase in body weight and no thermogenic alteration
Julie Minet-Ringuet et al.
APPETITE (2006)
Are females at special risk of obesity if they become psychotic?: The longitudinal Northern Finland 1966 Birth Cohort study
Helina Hakko et al.
SCHIZOPHRENIA RESEARCH (2006)
Differences in fecal microbiota in different European study populations in relation to age, gender, and country:: A cross-sectional study
S Mueller et al.
APPLIED AND ENVIRONMENTAL MICROBIOLOGY (2006)
Hormonal and metabolic effects of olanzapine and clozapine related to body weight in rodents
Vance L. Albaugh et al.
OBESITY (2006)
Effects of sub-chronic antipsychotic drug treatment on body weight and reproductive function in juvenile female rats
MJ Fell et al.
PSYCHOPHARMACOLOGY (2005)
Obesity alters gut microbial ecology
RE Ley et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
A parametric analysis of olanzapine-induced weight gain in female rats
GD Cooper et al.
PSYCHOPHARMACOLOGY (2005)
Research on adverse drug events.: I.: Muscarinic M3 receptor binding affinity could predict the risk of antipsychotics to induce type 2 diabetes
JS Silvestre et al.
METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY (2005)
Long-term treatment of ghrelin stimulates feeding, fat deposition, and alters the GH/IGF-I axis in the tilapia, Oreochromis mossambicus
LG Riley et al.
GENERAL AND COMPARATIVE ENDOCRINOLOGY (2005)
Olanzapine increases plasma ghrelin level in patients with schizophrenia
M Murashita et al.
PSYCHONEUROENDOCRINOLOGY (2005)
Current understanding of gender dimorphism in hepatic pathophysiology
Y Yokoyama et al.
JOURNAL OF SURGICAL RESEARCH (2005)
Ghrelin secretion is modulated in a nutrient- and gender-specific manner
Y Greenman et al.
CLINICAL ENDOCRINOLOGY (2004)
Adipokines: inflammation and the pleiotropic role of white adipose tissue
P Trayhurn et al.
BRITISH JOURNAL OF NUTRITION (2004)
Involvement of hypothalamic histamine H1 receptor in the regulation of feeding rhythm and obesity
T Masaki et al.
DIABETES (2004)
Gender differences in the prescribing of antipsychotic drugs
MV Seeman
AMERICAN JOURNAL OF PSYCHIATRY (2004)
Metabolic risk during antipsychotic treatment
JW Newcomer
CLINICAL THERAPEUTICS (2004)
Weight gain and new onset diabetes associated with olanzapine and risperidone
WR Farwell et al.
JOURNAL OF GENERAL INTERNAL MEDICINE (2004)
The gut microbiota as an environmental factor that regulates fat storage
F Bäckhed et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
The inflammatory syndrome: The role of adipose tissue cytokines in metabolic disorders linked to obesity
BE Wisse
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2004)
Interleukin-6 (IL-6) induces insulin resistance in 3T3-L1 adipocytes and is, like IL-8 and tumor necrosis factor-α, overexpressed in human fat cells from insulin-resistant subjects
V Rotter et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Atypical antipsychotic drug actions: unitary or multiple mechanisms for 'atypicality?
BL Roth et al.
CLINICAL NEUROSCIENCE RESEARCH (2003)
Antipsychotic dosing in preclinical models is often unrepresentative of the clinical condition: A suggested solution based on in vivo occupancy
S Kapur et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2003)
Chronic treatment with antipsychotics in rats as a model for antipsychotic-induced weight gain in human
B Pouzet et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2003)
HI-histamine receptor affinity predicts short-term weight gain for typical and atypical antipsychotic drugs
WK Kroeze et al.
NEUROPSYCHOPHARMACOLOGY (2003)
Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance
HY Xu et al.
JOURNAL OF CLINICAL INVESTIGATION (2003)
Clozapine-induced weight gain predicts improvement in psychopathology
HY Meltzer et al.
SCHIZOPHRENIA RESEARCH (2003)
A review of the effect of atypical antipsychotics on weight
H Nasrallah
PSYCHONEUROENDOCRINOLOGY (2003)
Plasma interleukin-8 concentrations are increased in obese subjects and related to fat mass and tumor necrosis factor-α system
M Straczkowski et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2002)
Association of antipsychotic drug-induced weight gain with a 5-HT2C receptor gene polymorphism
GP Reynolds et al.
LANCET (2002)
Molecular mechanisms for gender differences in susceptibility to T cell-mediated autoimmune diabetes in nonobese diabetic mice
M Bao et al.
JOURNAL OF IMMUNOLOGY (2002)
The atypical antipsychotic olanzapine enhances ingestive behaviour in the rat: a preliminary study
Z Thornton-Jones et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2002)
Sterol regulatory element binding protein 1c (SREBP-1c) expression in human obesity
M Kolehmainen et al.
OBESITY RESEARCH (2001)
A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans
DE Cummings et al.
DIABETES (2001)
C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus
AD Pradhan et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
Factors influencing acute weight change in patients with schizophrenia treated with olanzapine, haloperidol, or risperidone
BR Basson et al.
JOURNAL OF CLINICAL PSYCHIATRY (2001)
Share Paper
